Harrow (HROW) EBITDA Margin (2013 - 2026)
Harrow (HROW) reported EBITDA Margin of -7.10% for Q2 2026, down 32.41 percentage points from 25.31% a year earlier but up 30.21 percentage points from the prior quarter.
Harrow (HROW) EBITDA Margin (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Harrow's EBITDA Margin came in at 6.65%, down 7.17 percentage points year-over-year; for FY2025, it was 18.15%, up 6.90 percentage points from FY2024.
- EBITDA Margin has increased for four consecutive years, with a five-year change of +13.17 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at 11.25% in FY2024 (+2.00 pp), 9.25% in FY2023 (+3.64 pp), 5.61% in FY2022 (+0.80 pp) and 4.82% in FY2021 (-0.16 pp).
- Five-year quarterly EBITDA Margin spans a low of -37.32% in Q1 2026 and a high of 27.17% in Q3 2025.
- Year over year, EBITDA Margin has now declined in each of the last three quarters, with an average year-over-year change of -0.07 percentage points over the last eight quarters.
- The high point for year-over-year EBITDA Margin in five years was Q4 2024 (a gain of 31.58 percentage points); the low point was Q2 2026 (a drop of 32.41 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -37.32% (Q1 2026), 22.86% (Q4 2025) and 27.17% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Harrow | 1.18 Bn | 858.40 Mn | 50.36 Mn | -7.10% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7.10% |
| Mar 31, 2026 | -37.32% |
| Dec 31, 2025 | 22.86% |
| Sep 30, 2025 | 27.17% |
| Jun 30, 2025 | 25.31% |
| Mar 31, 2025 | -13.68% |
| Dec 31, 2024 | 26.10% |
| Sep 30, 2024 | 8.98% |
| Jun 30, 2024 | 9.26% |
| Mar 31, 2024 | -11.40% |
| Dec 31, 2023 | -5.48% |
| Sep 30, 2023 | 13.81% |
| Jun 30, 2023 | 16.71% |
| Mar 31, 2023 | 14.21% |
| Dec 31, 2022 | -4.98% |
| Sep 30, 2022 | 2.41% |
| Jun 30, 2022 | 10.77% |
| Mar 31, 2022 | 13.22% |
| Dec 31, 2021 | -6.31% |
| Sep 30, 2021 | -17.50% |
Harrow EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=HROW&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "HROW", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=HROW&period=max&api_key=YOUR_API_KEY");
const data = await res.json();